PLoS ONE (Jan 2010)

Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

  • Susanne Krasemann,
  • Melanie Neumann,
  • Markus Geissen,
  • Walter Bodemer,
  • Franz-Josef Kaup,
  • Walter Schulz-Schaeffer,
  • Nathalie Morel,
  • Adriano Aguzzi,
  • Markus Glatzel

DOI
https://doi.org/10.1371/journal.pone.0013906
Journal volume & issue
Vol. 5, no. 11
p. e13906

Abstract

Read online

Prion diseases are transmissible fatal neurodegenerative disorders affecting humans and animals. A central step in disease progression is the accumulation of a misfolded form (PrP(Sc)) of the host encoded prion protein (PrP(C)) in neuronal and non-neuronal tissues. The involvement of peripheral tissues in preclinical states increases the risk of accidental transmission. On the other hand, detection of PrP(Sc) in non-neuronal easy-accessible compartments such as muscle may offer a novel diagnostic tool. Primate models have proven invaluable to investigate prion diseases. We have studied the deposition of PrP(Sc) in muscle and central nervous system of rhesus monkeys challenged with sporadic Creutzfeldt-Jakob disease (sCJD), variant CJD (vCJD) and bovine spongiform encephalopathy (BSE) in preclinical and clinical stage using biochemical and morphological methods. Here, we show the preclinical presence of PrP(Sc) in muscle and central nervous system of rhesus monkeys experimentally infected with vCJD.